{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:57:17Z","timestamp":1695509837194},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1920,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1111\/j.1399-3062.2010.00519.x","type":"journal-article","created":{"date-parts":[[2010,5,31]],"date-time":"2010-05-31T07:03:24Z","timestamp":1275289404000},"page":"428-431","source":"Crossref","is-referenced-by-count":1,"title":["Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients"],"prefix":"10.1111","volume":"12","author":[{"given":"E.","family":"Vigna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"De Vivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.","family":"Recchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Vianelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,30]]},"reference":[{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB1|cit1","first-page":"1","article-title":"Leishmania and the leishmaniases","volume":"64","author":"Ba\u00f1uls","year":"2007","journal-title":"a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB2|cit2","unstructured":"World Health Organization http:\/\/www.who.int\/health-topics\/leishmaniasis.htm"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB3|cit3","first-page":"19","article-title":"Les leishmanioses de'clare'es en France en 1999","volume":"5","author":"Basset","year":"2001","journal-title":"BEH"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB4|cit4","first-page":"191","article-title":"Treatment of Mediterranean visceral leishmaniasis","volume":"73","author":"Gradoni","year":"1995","journal-title":"Bull World Health Organ"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1128\/AAC.42.12.3097","article-title":"Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action","volume":"42","author":"Sereno","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0035-9203(01)90160-9","article-title":"Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India","volume":"95","author":"Thakur","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.1989.40.159","article-title":"Biochemistery of Pentostam resistant Leishmania","volume":"40","author":"Berman","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4269\/ajtmh.1991.44.394","article-title":"Efficacy and toxicity of Pentostam against Panamanian mucosal leishmaniasis","volume":"44","author":"Saenz","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(94)90406-5","article-title":"Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar","volume":"344","author":"Mishra","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB10|cit10","first-page":"319","article-title":"Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions","volume":"93","author":"Thakur","year":"1999","journal-title":"a study of 938 cases"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB11|cit11","first-page":"75","article-title":"Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis","volume":"87","author":"Davidson","year":"1994","journal-title":"a multi-centre trial"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/515085","article-title":"U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0035-9203(95)90557-X","article-title":"Treatment of kalaazar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days","volume":"89","author":"Dietze","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/003655400459612","article-title":"Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients","volume":"32","author":"Gaeta","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-127-2-199707150-00007","article-title":"Short-course, low dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony","volume":"127","author":"Sundar","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(08)70043-4","article-title":"Leishmaniasis among organ transplant recipients","volume":"8","author":"Antinori","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"934","DOI":"10.7326\/0003-4819-113-12-934","article-title":"Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis","volume":"113","author":"Franke","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(83)90595-0","article-title":"Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials","volume":"3","author":"Veiga","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/clinids\/18.1.83","article-title":"Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis","volume":"18","author":"Gasser","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0035-9203(87)90354-3","article-title":"A new Leishmania infantum enzymatic variant, agent of an urban visceral case unresponsive to drugs","volume":"81","author":"Gradoni","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/infdis\/156.5.784","article-title":"Induction of prostaglandin synthesis as the mechanism responsible for chills and fever produced by infusing amphotericin B","volume":"156","author":"Gigliotti","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/clinids\/20.1.191","article-title":"Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus","volume":"20","author":"Torre-Cisneros","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/clinids\/22.6.938","article-title":"Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)","volume":"22","author":"Davidson","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3476(97)70165-3","article-title":"Treatment of visceral leishmaniasis in children with liposomal amphotericin B","volume":"131","author":"Di Martino","year":"1997","journal-title":"J Pediatr"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB26|cit26","first-page":"49","article-title":"Editorial response","volume":"28","author":"Berman","year":"1999","journal-title":"U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0035-9203(93)90045-R","article-title":"Efficacy and tolerability of liposomal amphotericin B in Italian infants with visceral leishmaniasis","volume":"87","author":"Di Martino","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB28|cit28","first-page":"157","article-title":"Visceral leishmaniasis","volume":"73","author":"Smith","year":"1995","journal-title":"rapid response to AmBisome treatment"},{"key":"10.1111\/j.1399-3062.2010.00519.x-BIB29|cit29","first-page":"599","article-title":"Leishmaniasis","volume":"16","author":"Kedzierski","year":"2009","journal-title":"current treatment and prospects for new drugs and vaccines"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2010.00519.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-3062.2010.00519.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:14:18Z","timestamp":1625620458000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2010.00519.x"}},"subtitle":["L-AMB for visceral leishmaniasis"],"short-title":[],"issued":{"date-parts":[[2010,5,30]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2010.00519.x","relation":{},"ISSN":["1398-2273"],"issn-type":[{"value":"1398-2273","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5,30]]}}}